Company Filing History:
Years Active: 2014-2015
Title: Celebrating the Innovations of Cheryl L. Weed in Antibody Purification
Introduction: Cheryl L. Weed is a prominent inventor based in Scituate, Rhode Island, who has made significant contributions to the biotechnology field. With a focus on the isolation and purification of antibodies, Cheryl holds two patents that are essential for pharmaceutical applications. Her innovative work enhances the capability of producing pure antibody compositions for medical use, benefiting both research and clinical settings.
Latest Patents: Cheryl L. Weed's latest patents include methods for the isolation and purification of antibodies using Protein A affinity chromatography. The disclosed methodologies incorporate several steps such as pH viral reduction/inactivation, ultrafiltration/diafiltration, and various chromatography techniques, including ion exchange and hydrophobic chromatography. These advancements ensure that the resultant antibody compositions are sufficiently pure for pharmaceutical applications, demonstrating her expertise in bioprocessing.
Career Highlights: Cheryl works for AbbVie Inc., a global biopharmaceutical company, where she applies her extensive knowledge and experience in developing innovative solutions for complex biomedical challenges. Her role empowers her to contribute to groundbreaking therapies that can alleviate various health conditions, showcasing her dedication to advancing medical science.
Collaborations: Throughout her career, Cheryl has collaborated with talented professionals such as Robert K. Hickman and Qing Huang. These collaborations enhance the research and development efforts at AbbVie Inc., enabling the team to leverage diverse expertise in the pursuit of excellence in antibody purification techniques.
Conclusion: Cheryl L. Weed's innovative contributions to the field of antibody purification not only reflect her talent as an inventor but also underline the importance of collaboration in scientific advancements. Her patents signify a step forward in the pharmaceutical industry, facilitating the development of safer and more effective antibody-based therapies. Cheryl's work stands as an inspiration for future inventors aiming to make meaningful impacts in biotechnology and healthcare.